Atipamezole Impurity 10 | CAS 161695-24-5 - Request Quote
Atipamezole Impurity 10
| SZ CAT No: | SZ-A176011 |
| CAS No | 161695-24-5 |
| Mol.F. | C13H15BrO |
| Mol.Wt. | 267.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Atipamezole Impurity 10 is chemically 2-bromo-1-(2-ethyl-2,3-dihydro-1H-inden-2-yl)ethan-1-one. Atipamezole Impurity 10 is supplied with detailed characterization data compliant with regulatory guideline. Atipamezole Impurity 10 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Atipamezole.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 161695-24-5
Purchase 161695-24-5
Order 161695-24-5
Enquire 161695-24-5
price of 161695-24-5
161695-24-5 Supplier
161695-24-5 Manufacturer
161695-24-5 Exporter
buy high quality Atipamezole Impurity 10
Purchase Atipamezole Impurity 10
Atipamezole Impurity 10 suppliers
Atipamezole Impurity 10 manufacturers
Atipamezole Impurity 10 price
Order Atipamezole Impurity 10
Enquire Atipamezole Impurity 10
Atipamezole Impurity 10 cost
Atipamezole Impurity 10 Supplier
Atipamezole Impurity 10 Distributor
Atipamezole Impurity 10 for Method Validation
Atipamezole Reference Standard
Atipamezole Impurity 10 for ANDA Filing
Atipamezole Impurity 10 for Forced Degradation Studies
Atipamezole Impurity 10 Identification Standards
Atipamezole Impurity 10 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.